Medicover AB/Skr MCOV B
08:00
10:05
12:15
14:20
16:25
1D1W1MYTD1Y5YMAX
About Medicover AB
Medicover AB is a healthcare company that operates in the medical care and diagnostic services industry. It provides a wide range of healthcare services, including preventive care, specialist consultations, and surgeries, as well as laboratory and diagnostic tests. Founded in 1995, Medicover has developed a significant presence in Central and Eastern Europe, with its headquarters located in Stockholm, Sweden. The company strategically positions itself to offer both insurance services and healthcare services, allowing it to leverage synergies between these segments. It continues to expand its geographic footprint through acquisitions and organic growth, aiming to provide comprehensive healthcare solutions across its markets.
Ticker
Skr MCOV B
Sector
Primary listing
XSTO
Employees
49,000
Headquarters
Stockholm, Sweden
Website
Medicover AB Metrics
BasicAdvanced
kr 30B
36.62
kr 5.52
1.58
kr 1.64
0.81%
Price and volume
Market cap
kr 30B
Beta
1.58
52-week high
kr 295.00
52-week low
kr 183.40
Average daily volume
93K
Dividend rate
kr 1.64
Financial strength
Current ratio
0.702
Quick ratio
0.607
Long term debt to equity
200.936
Total debt to equity
264.232
Dividend payout ratio (TTM)
29.03%
Interest coverage (TTM)
2.46%
Profitability
EBITDA (TTM)
2,975.38
Gross margin (TTM)
23.16%
Net profit margin (TTM)
3.26%
Operating margin (TTM)
6.62%
Effective tax rate (TTM)
26.12%
Revenue per employee (TTM)
kr 537,650
Management effectiveness
Return on assets (TTM)
4.32%
Return on equity (TTM)
14.06%
Valuation
Price to earnings (TTM)
36.619
Price to revenue (TTM)
1.19
Price to book
57.24
Price to tangible book (TTM)
-108.8
Price to free cash flow (TTM)
15.253
Free cash flow yield (TTM)
6.56%
Free cash flow per share (TTM)
13.243
Dividend yield (TTM)
0.81%
Forward dividend yield
0.81%
Growth
Revenue change (TTM)
13.69%
Earnings per share change (TTM)
360.59%
3-year revenue growth (CAGR)
16.34%
10-year revenue growth (CAGR)
19.06%
3-year earnings per share growth (CAGR)
86.57%
10-year earnings per share growth (CAGR)
2.83%
3-year dividend per share growth (CAGR)
18.56%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
Capital at risk
Upcoming events
FAQs
What’s the current market cap for Medicover AB stock?
Medicover AB (MCOV B) has a market cap of Skr30B as of March 18, 2026.
What is the P/E ratio for Medicover AB stock?
The price to earnings (P/E) ratio for Medicover AB (MCOV B) stock is 36.62 as of March 18, 2026.
Does Medicover AB stock pay dividends?
Yes, the Medicover AB (MCOV B) stock pays dividends to shareholders. As of March 18, 2026, the dividend rate is Skr1.63954 and the yield is 0.81%. Medicover AB has a payout ratio of 29.03% on a trailing twelve-month basis.
When is the next Medicover AB dividend payment date?
The next Medicover AB (MCOV B) dividend payment is scheduled for May 11, 2026.
What is the beta indicator for Medicover AB?
Medicover AB (MCOV B) has a beta rating of 1.58. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.